Athersys Names Ivor Macleod Chief Financial Officer
15 janv. 2020 06h00 HE
|
Athersys, Inc.
CLEVELAND, Jan. 15, 2020 (GLOBE NEWSWIRE) -- Athersys, Inc. (NASDAQ: ATHX) announced today the addition of Mr. Ivor Macleod, CPA, MBA, a highly experienced pharmaceutical executive, to the Athersys...
Athersys Provides Update on One-Year ARDS Study Data
14 janv. 2020 06h00 HE
|
Athersys, Inc.
CLEVELAND, Jan. 14, 2020 (GLOBE NEWSWIRE) -- Athersys, Inc. (NASDAQ: ATHX) announced today the one-year follow-up summary results from its exploratory clinical study of the intravenous...
Healios Receives Notification of Orphan Designation for Acute Respiratory Distress Syndrome Clinical Program
14 nov. 2019 06h00 HE
|
Athersys, Inc.
CLEVELAND, Nov. 14, 2019 (GLOBE NEWSWIRE) -- Athersys, Inc. (Nasdaq: ATHX) announced today that its collaborator in Japan, HEALIOS K.K. (“Healios”) received notification this week from the...
Athersys Reports Third Quarter 2019 Results
06 nov. 2019 16h05 HE
|
Athersys, Inc.
CLEVELAND, Nov. 06, 2019 (GLOBE NEWSWIRE) -- Athersys, Inc. (NASDAQ: ATHX) announced today its financial results for the three months ended September 30, 2019. Highlights of the third quarter of...
Athersys to Host Third Quarter Financial Results Call
14 oct. 2019 13h00 HE
|
Athersys, Inc.
CLEVELAND, Oct. 14, 2019 (GLOBE NEWSWIRE) -- Athersys, Inc. (Nasdaq: ATHX) will release its third quarter 2019 financial results at approximately 4:00 PM Eastern Time on Wednesday, November 6, 2019,...
Athersys to Present at 2019 Cell & Gene Meeting on the Mesa
25 sept. 2019 08h00 HE
|
Athersys, Inc.
CLEVELAND, Sept. 25, 2019 (GLOBE NEWSWIRE) -- Athersys, Inc. (NASDAQ: ATHX) announced today that Dr. Gil Van Bokkelen, Chairman and CEO, will present at the annual Cell & Gene Meeting on the...
Athersys Reports Second Quarter 2019 Results
07 août 2019 16h05 HE
|
Athersys, Inc.
CLEVELAND, Aug. 07, 2019 (GLOBE NEWSWIRE) -- Athersys, Inc. (NASDAQ: ATHX) announced today its financial results for the three months ended June 30, 2019. Highlights of the second quarter of 2019...
Athersys to Host Second Quarter Financial Results Call
08 juil. 2019 11h00 HE
|
Athersys, Inc.
CLEVELAND, July 08, 2019 (GLOBE NEWSWIRE) -- Athersys, Inc. (Nasdaq: ATHX) will release its second quarter 2019 financial results at approximately 4:00 PM Eastern Time on Wednesday, August 7, 2019,...
Athersys to Present at Jefferies 2019 Healthcare Conference
04 juin 2019 06h00 HE
|
Athersys, Inc.
CLEVELAND, June 04, 2019 (GLOBE NEWSWIRE) -- Athersys, Inc. (NASDAQ: ATHX) announced today that Dr. Gil Van Bokkelen, Chairman and CEO, will present at the Jefferies 2019 Healthcare Conference...
Athersys to Participate in four Events at the International Society of Cell and Gene Therapy Conference
28 mai 2019 06h00 HE
|
Athersys, Inc.
CLEVELAND, May 28, 2019 (GLOBE NEWSWIRE) -- Athersys, Inc. (NASDAQ: ATHX) announced today its participation in several sessions at this year’s International Society for Cell and Gene Therapy (ISCT)...